|
References
1. American Medical Association. Current Procedural Terminology, 2008. Available at www.ama-assn.org.
2. Acharya, C.R., Hsu, D.S., Anders, C.K., Anguiano, A., et al. (2008). Gene expression signatures, clinicopathologic features, and individualized therapy in breast cancer. Journal of the American Medical Association, 299(13), 1574-87.
3. Huang, C-C., & Bredel, M. (2008). Use of gene signatures to improve risk estimation in cancer. JAMA, 299(13), 1605-6.
4. 42 U.S.C. §1395y(a)(1)(A) (2000); see also Centers for Medicare & Medicaid Services, U.S. Department of Health and Human Services, Pub. No. 100-2, Medicare Benefit Policy Manual, chapters 16 and 20. Available at www.cms.hhs.gov/manuals/downloads/bp102c16.pdf
|